首页> 美国卫生研究院文献>Oxford Open >1052. Do Healthcare Providers De-Escalate β-Lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli and Klebsiella pneumoniae From the Veterans Health Administration (VHA)
【2h】

1052. Do Healthcare Providers De-Escalate β-Lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli and Klebsiella pneumoniae From the Veterans Health Administration (VHA)

机译:1052.医疗保健提供者是否根据抗生素药敏试验(AST)的结果降低β-内酰胺(BL)抗生素的治疗水平?退伍军人卫生管理局(VHA)分析由大肠杆菌和肺炎克雷伯菌引起的血流感染(BSI)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAchieving appropriate therapy for BSI caused by Gram-negative rods (GNR) is challenging. The availability of AST results allows de-escalation from broad- to narrow-spectrum agents. De-escalation is a goal of antimicrobial stewardship (AS). Through the analysis of inpatient BL antibiotic regimens in a nationwide cohort of patients with Escherichia coli and Klebsiella pneumoniae BSI, we compared the relative spectrum of empiric and definitive treatments to AST results and identified opportunities for de-escalation.
机译:背景对于由革兰氏阴性棒(GNR)引起的BSI采取适当的治疗方法具有挑战性。 AST结果的可用性允许从广谱代理到窄谱代理的逐步升级。降级是抗菌素管理(AS)的目标。通过分析全国范围内大肠埃希菌和肺炎克雷伯菌BSI患者的BL抗生素治疗方案,我们比较了经验性和确定性治疗相对于AST结果的相对范围,并确定了降级的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号